Drugs comprising in association at least one immunotoxin and at

Drug – bio-affecting and body treating compositions – Lymphokine

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530387, 530388, 530389, 530390, 530391, 530828, 514 6, 514 8, A61K 3900, C07K 1300

Patent

active

047676213

ABSTRACT:
The present invention relates to drugs characterized in that they comprise, in association, at least one immunotoxin and at least one monovalent carboxylic ionophore.

REFERENCES:
Biswajit Ray et al, Chemical Abstracts, V. 95, No. 36779m, "Enhanced Internalization . . . Ovary Cells".
Biswajit Ray et al, Chemical Abstracts, V. 95, No. 75056t, "Enhancement of Cytotoxicities . . . Nigericin".
Ray et al, Mol Cell Biol, vol. 1(6), pp. 552-559, "Enhancement of Cytotoxicities of Ricin and Pseudomonas Toxin in Chinese Hamster Ovary Cells by Nigericin".
Ray et al, Mol Cell Biol, vol. 1(6), pp. 560-567, "Enhanced Internalization of Ricin in Nigericin-Pretreated Chinese Hamster Ovary Cells".
Alonso et al, FEBS Lett., vol. 127(1), pp. 112-114, 1981, "Permeabilization of Mammalian Cells to Proteins by the Ionophore Nigericin".
Moolten et al, Immunol Rev., vol. 62, pp. 47-73.
Sandvig et al, J Biol Chem, vol. 257, pp. 7504-7513.
Jansen et al, Immunol Rev, vol. 62, pp. 185-216.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Drugs comprising in association at least one immunotoxin and at does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drugs comprising in association at least one immunotoxin and at , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drugs comprising in association at least one immunotoxin and at will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2087486

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.